Objective To evaluate the efficiency of exogenously administered vitamin A
in preventing renal scarring caused by experimental pyelonephritis in rats.
Materials and methods Forty Wistar rats were injected with 0.1 mL of soluti
on containing Escherichia coli (10(10)/mL) into both renal medullae. Five e
qual groups were then formed: group I was treated only with ciprofloxacin (
30 mg/kg per day, twice daily, intraperitoneally) for 5 days, starting 3 da
ys after bacterial inoculation; in group 2, 60 kIU of vitamin A was injecte
d intramuscularly with the bacterial inoculation; in group 3, 60 KIU of vit
amin A was injected similarly, but 3 days after bacterial inoculation; in g
roup 4, 60 kIU of vitamin A was given orally with the bacterial inoculation
; and group 5 was treated with ciprofloxacin for 5 days and vitamin A intra
muscularly from the third day after bacterial inoculation. All the rats wer
e killed 6 weeks after bacterial injection; blood samples were obtained to
determine serum vitamin A and p-carotene levers, and both kidneys were exam
ined pathologically for scarring, graded as 0 (none), 1 (mild), 2 (moderate
) and 3 (severe).
Results Serum Vitamin A levers were higher in the rats given vitamin A (gro
up 2-5) than in group 1, being highest in group 4, although only this group
had significantly higher levels of vitamin A than group 1 (P < 0.05). Hist
opathologically, the fibrosis was mildest in groups 2 and 4 (two of 16 kidn
eys grade 1), whereas it was most severe in group 1 (all 16 grade 2-3). Fib
rosis was significantly less in groups 2-5 than in group 1 (P < 0.05). Ther
e was a significant negative correlation between vitamin A levels and the s
um of the fibrosis, inflammation and tubular atrophy scores of all rats (r
= -0.391, P < 0.02). P-carotene levels were unrelated to renal scarring.
Conclusion The administration of vitamin A could have a role in preventing
renal scar formation from pyelonephritis induced experimentally in rats.